621 related articles for article (PubMed ID: 33936066)
21. Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study.
Fang G; Kong F; Zhang H; Huang B; Zhang J; Zhang X
Front Immunol; 2023; 14():1168188. PubMed ID: 37228614
[TBL] [Abstract][Full Text] [Related]
22. Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study.
Lu H; Wu PF; Zhang W; Xia K
Mult Scler Relat Disord; 2020 Sep; 44():102300. PubMed ID: 32590313
[TBL] [Abstract][Full Text] [Related]
23. Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study.
Pan R; Xiao M; Wu Z; Liu J; Wan L
Front Immunol; 2023; 14():1276257. PubMed ID: 37942318
[TBL] [Abstract][Full Text] [Related]
24. Basal metabolic rate and risk of multiple sclerosis: a Mendelian randomization study.
Liu C; Lu Y; Chen J; Qiu W; Zhan Y; Liu Z
Metab Brain Dis; 2022 Aug; 37(6):1855-1861. PubMed ID: 35543713
[TBL] [Abstract][Full Text] [Related]
25. Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis.
Lin J; Zhou J; Xu Y
Brain; 2023 Aug; 146(8):3364-3372. PubMed ID: 36864689
[TBL] [Abstract][Full Text] [Related]
26. Chickenpox and multiple sclerosis: A Mendelian randomization study.
Zhu G; Zhou S; Xu Y; Gao R; Zhang M; Zeng Q; Su W; Wang R
J Med Virol; 2023 Jan; 95(1):e28315. PubMed ID: 36380510
[TBL] [Abstract][Full Text] [Related]
27. Effect of age at puberty on risk of multiple sclerosis: A mendelian randomization study.
Harroud A; Morris JA; Forgetta V; Mitchell R; Smith GD; Sawcer SJ; Richards JB
Neurology; 2019 Apr; 92(16):e1803-e1810. PubMed ID: 30894442
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory biomarkers and risk of ischemic stroke and subtypes: A 2-sample Mendelian randomization study.
Lin J; Wang Y; Wang Y; Pan Y
Neurol Res; 2020 Feb; 42(2):118-125. PubMed ID: 31900081
[No Abstract] [Full Text] [Related]
29. Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study.
Mitchell RE; Bates K; Wootton RE; Harroud A; Richards JB; Davey Smith G; Munafò MR
PLoS Biol; 2020 Nov; 18(11):e3000973. PubMed ID: 33253141
[TBL] [Abstract][Full Text] [Related]
30. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study.
Johnson KE; Siewert KM; Klarin D; Damrauer SM; ; Chang KM; Tsao PS; Assimes TL; Maxwell KN; Voight BF
PLoS Med; 2020 Sep; 17(9):e1003302. PubMed ID: 32915777
[TBL] [Abstract][Full Text] [Related]
31. Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study.
Xiong H; Zhang H; Bai J; Li Y; Li L; Zhang L
BMC Cancer; 2024 Apr; 24(1):531. PubMed ID: 38671390
[TBL] [Abstract][Full Text] [Related]
32. Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis.
Ge F; Huo Z; Li C; Wang R; Wang R; Liu Y; Chen J; Lu Y; Wen Y; Jiang Y; Peng H; Wu X; Liang H; He J; Liang W
Mult Scler Relat Disord; 2021 Jun; 51():102927. PubMed ID: 33812221
[TBL] [Abstract][Full Text] [Related]
33. A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study.
Liao Q; He J; Tian FF; Bi FF; Huang K
Front Immunol; 2022; 13():922922. PubMed ID: 35911771
[TBL] [Abstract][Full Text] [Related]
34. Genetically predicted telomere length and multiple sclerosis.
Shu MJ; Li J; Zhu YC
Mult Scler Relat Disord; 2022 Apr; 60():103731. PubMed ID: 35339005
[TBL] [Abstract][Full Text] [Related]
35. Causal relationships between interleukins, interferons and COVID-19 risk: a Mendelian randomization study.
Wang C; Wang X; Zhang S; Xu P; Cheng L
Int J Environ Health Res; 2024 May; 34(5):2387-2396. PubMed ID: 37660260
[TBL] [Abstract][Full Text] [Related]
36. Mendelian randomization study for the roles of IL-18 and IL-1 receptor antagonist in the development of inflammatory bowel disease.
Mi J; Liu Z; Pei S; Wu X; Zhao N; Jiang L; Zhang Z; Bai X
Int Immunopharmacol; 2022 Sep; 110():109020. PubMed ID: 35843146
[TBL] [Abstract][Full Text] [Related]
37. Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics.
Jeong S; Tsai MJ; Shen C; Hsu YH
J Bone Miner Metab; 2024 May; 42(3):335-343. PubMed ID: 38801451
[TBL] [Abstract][Full Text] [Related]
38. Ten interleukins and risk of prostate cancer.
Li BH; Yan SY; Luo LS; Zeng XT; Wang YB; Wang XH
Front Oncol; 2023; 13():1108633. PubMed ID: 36733309
[TBL] [Abstract][Full Text] [Related]
39. Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis.
Wang R
J Transl Med; 2022 Jan; 20(1):3. PubMed ID: 34980161
[TBL] [Abstract][Full Text] [Related]
40. Myocardial infarction and stroke risks in multiple sclerosis patients: A two-sample Mendelian randomization study.
Peng H; Wu X; Wen Y; Lin J; Guan W
Mult Scler Relat Disord; 2022 Feb; 58():103501. PubMed ID: 35066269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
